Cel-Sci
CVM
#10616
Rank
HK$0.15 B
Marketcap
HK$9.10
Share price
-4.92%
Change (1 day)
-87.74%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of March 2026 : HK$66.75 Million

According to Cel-Sci 's latest financial reports the company's total debt is HK$66.75 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-09-30HK$73.02 M-19.17%
2024-09-30HK$90.34 M-14.99%
2023-09-30HK$0.10 B-11.53%
2022-09-30HK$0.12 B-3.4%
2021-09-30HK$0.12 B15.14%
2020-09-30HK$0.10 B2.01%
2019-09-30HK$0.10 B1.09%
2018-09-30HK$0.10 B-5.59%
2017-09-30HK$0.11 B9.94%
2016-09-30HK$0.10 B-6.23%
2015-09-30HK$0.10 B1135.84%
2014-09-30HK$8.7 M-0.91%
2013-09-30HK$8.78 M2.67%
2012-09-30HK$8.56 M-78.02%
2011-09-30HK$38.94 M354.6%
2010-09-30HK$8.56 M-0.17%
2009-09-30HK$8.58 M452.41%
2008-09-30HK$1.55 M
2005-09-30HK$0.02 M-0.45%
2004-09-30HK$0.02 M-99.65%
2003-09-30HK$6.76 M-51.09%
2002-09-30HK$13.83 M5584.11%
2001-09-30HK$0.24 M25.84%
2000-09-30HK$0.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.20 B 645,876.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$449.52 B 673,319.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$1.37 B 1,957.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
HK$10.48 M-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.58 B 198,520.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
HK$6.41 B 9,506.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.49 B 6,638.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$3.05 M-95.43%๐Ÿ‡บ๐Ÿ‡ธ USA